Abstract
Background
Neuropathic pain is more common among older people than in the general population, and the efficacy of medical treatment often remains unsatisfactory.
Objective
The aim of this study was to assess the presence, diagnostic certainty, etiology and treatment of neuropathic pain in community-dwelling older people with chronic pain.
Methods
Independently living older people aged 75, 80 and 85 years subject to communal preventive home visits with chronic pain were invited to a clinical pain examination by a geriatrician.
Results
Overall, 106 patients consented to participate in the clinical study. Neuropathic pain was diagnosed in 51 (48 %) patients, with 75 % of pain states definite and 25 % probable neuropathic pain. The most common etiology was degenerative disease of the spinal column causing radiculopathy. At the study visit, 11 patients (22 % of neuropathic pain patients) were receiving medication that was demonstrated to be effective against neuropathic pain. The geriatrician recommended a trial of a new medicine for 17 patients, but only six continued the medication going forward.
Conclusions
Neuropathic pain was surprisingly common in our cohort. Finding effective pain medication is challenging due to comorbidities, possible side effects, and vulnerability in older age. Other pain management methods should be considered.
Similar content being viewed by others
References
International Association for the Study of Pain. IASP taxonomy. Available at: http://www.iasp-pain.org/Taxonomy?navItemNumber=576#Peripheralneuropathicpain. Accessed Feb 2015.
Smith BH, Torrance N. Epidemiology of neuropathic pain and its impact on quality of life. Curr Pain Headache Rep. 2012;16:191–8.
Bouhassira D, Lanteri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2008;136:380–7.
Torrance N, Smith BH, Bennett MI, Lee AJ. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain. 2006;7:281–9.
van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 2014;155:654–62.
Dieleman JP, Kerklaan J, Huygen FJ, Bouma PA, Sturkenboom MC. Incidence rates and treatment of neuropathic pain conditions in the general population. Pain. 2008;137:681–8.
Hall GC, Carroll D, Parry D, McQuay HJ. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain. 2006;122:156–62.
Haanpää M, Backonja M, Bennett M, Bouhassira D, Cruccu G, Hansson P, et al. Assessment of neuropathic pain in primary care. Am J Med. 2009;122(10 Suppl):S13–21.
Haanpää M, Attal N, Backonja M, Baron R, Bennett M, Bouhassira D, et al. NeuPSIG guidelines on neuropathic pain assessment. Pain. 2011;152:14–27.
Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, et al. Redefinition of neuropathic pain and a grading system for clinical use: consensus statement on clinical and research diagnostic criteria. Neurology. 2008;70:1630–5.
Finnerup NB, Attal N, Haroutian S, McNicol E, Baron R, Dworkin RH, et al. Pharmacotherapy of neuropathic pain in adults: systematic review, meta-analysis and NeuPSIG recommendations. Lancet Neurol. 2015;14(2):162–73.
National Institute for Health and Care Excellence (NICE). Neuropathic pain—pharmacological management. The pharmacological management of neuropathic pain in adults in non-specialist settings. NICE clinical guideline 173. 2013. Available at: http://www.nice.org.uk/guidance/CG173. Accessed Feb 2015.
Cruccu G, Aziz L, Garcia-Larrea L, et al. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol. 2007;14:952–70.
Attal N, Lanteri-Minet M, Laurent B, Fermanian J, Bouhassira D. The specific disease burden of neuropathic pain: results of a French nationwide survey. Pain. 2011;152:2836–43.
Dworkin RH, Panarites CJ, Armstrong EP, Malone DC, Pham SV. Is treatment of postherpetic neuralgia in the community consistent with evidence-based recommendations? Pain. 2012;153:869–75.
Torrance N, Ferguson JA, Afolabi E, Bennett MI, Serpell MG, Dunn KM, et al. Neuropathic pain in the community: more under-treated than refractory? Pain. 2013;154:690–9.
Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken). 2011;63(Suppl 11):S240–52.
Cleeland CR, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med. 1994;23:130–8.
Freynhagen R, Baron R, Gockel U, Tölle TR. PainDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006;22:1911–20.
Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol. 1986;5:165–73.
Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893–7.
Radat F, Margot-Duclot A, Attal N. Psychiatric co-morbidities in patients withcchronic peripheral neuropathic pain: a multicentre cohort study. Eur J Pain. 2013;17:1547–57.
Schmader KE, Baron R, Haanpää ML, Mayer J, O’Connor AB, Rice AS, et al. Treatment considerations for elderly and frail patients with neuropathic pain. Mayo Clin Proc. 2010;85(3 Suppl):S26–32.
Sawynok J. Topical analgesics for neuropathic pain in the elderly: current and future prospects. Drugs Aging. 2014;31:853–62.
Torrance N, Smith BH, Watson MC, Bennett MI. Medication and treatment use in primary care patients with chronic pain in predominantly neuropathic origin. Fam Pract. 2007;24:481–5.
Ahmad M, Goucke C. Management strategies for the treatment of neuropathic pain in the elderly. Drugs Aging. 2002;19:929–45.
Acknowledgments
Susanna Rapo-Pylkkö, Maija Haanpää and Helena Liira participated in the design of the study and writing of this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This study received financial support from the research fund of Orton, and all authors appreciate the support for this study.
Conflict of interest
Susanna Rapo-Pylkkö, Maija Haanpää and Helena Liira declare that they have no conflicts of interest relevant to the content of this study.
Ethical approval
All procedures performed in studies involving human participants were in accordance with ethical standards of the Institutional Research Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study protocol was approved by the Ethics Committee of the Helsinki University Central Hospital (permission 128/13/03/00/09), and written informed consent was obtained from all participants.
Rights and permissions
About this article
Cite this article
Rapo-Pylkkö, S., Haanpää, M. & Liira, H. Neuropathic Pain Among Community-Dwelling Older People: A Clinical Study in Finland. Drugs Aging 32, 737–742 (2015). https://doi.org/10.1007/s40266-015-0294-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40266-015-0294-5